Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;129(1):55-63.
doi: 10.1007/s00702-021-02447-4. Epub 2021 Dec 23.

Levodopa-induced dyskinesias in Parkinson's disease increase cerebrospinal fluid nitric oxide metabolites' levels

Bruno L Santos-Lobato  1   2 , Mariza Bortolanza  3 , Lucas César Pinheiro  4 , Marcelo E Batalhão  4 , Ângela V Pimentel  1 , Evelin Capellari-Carnio  4 , Elaine A Del-Bel  3 , Vitor Tumas  5
Affiliations

Levodopa-induced dyskinesias in Parkinson's disease increase cerebrospinal fluid nitric oxide metabolites' levels

Bruno L Santos-Lobato et al. J Neural Transm (Vienna). 2022 Jan.

Abstract

Levodopa-induced dyskinesia (LID) is a common complication of Parkinson's disease (PD) therapy. Nitric oxide in the central nervous system may have a role in its pathophysiology. The present work investigates plasma and CSF levels of nitric oxide metabolites nitrite and nitrate in patients with PD, LID, and healthy control. We measured plasma and CSF nitrite and nitrate levels in patients with PD with and without LID and in healthy controls. The levels of plasma and CSF nitrite and nitrate were measured by ozone-based chemiluminescence. Sixty-seven participants were enrolled. CSF nitrite levels in patients with PD and LID were higher than in patients with PD without LID and healthy controls. CSF/plasma ratio of nitrite was higher in patients with PD and LID than in patients with PD without LID. The CSF/plasma ratio of nitrite in patients with PD and LID was higher than 1, indicating an intrathecal production of NO in patients with this motor complication. There was an increase in nitrate levels of CSF and CSF/plasma ratio of nitrate in patients with PD and LID compared to the healthy controls. Sex, age at evaluation, disease duration, and levodopa equivalent daily doses, as well as processing and storage time, did not critically influence these results. The present study demonstrated an increase in nitrite and nitrate levels in the central nervous system of patients with PD and LID. This finding strengthens the role of NO on LID pathophysiology.

Keywords: Dyskinesia; Levodopa; Nitric oxide; Parkinson’s disease.

PubMed Disclaimer

References

    1. Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson’s disease. Neurobiol Dis 6:461–474. https://doi.org/10.1006/nbdi.1999.0259 - DOI - PubMed
    1. Böckelmann R, Wolf G, Ransmayr G, Riederer P (1994) NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson’s disease putamen. J Neural Transm Park Dis Dement Sect 7:115–121. https://doi.org/10.1007/BF02260966 - DOI - PubMed
    1. Boll M-C, Alcaraz-Zubeldia M, Montes S, Rios C (2008) Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 33:1717–1723. https://doi.org/10.1007/s11064-008-9610-3 - DOI - PubMed
    1. Cristalli DO, Arnal N, Marra FA, Alaniz MJT, Marra CA (2012) Peripheral markers in neurodegenerative patients and their first-degree relatives. J Neurol Sci 314:48–56. https://doi.org/10.1016/j.jns.2011.11.001 - DOI - PubMed
    1. Çubukçu HC, Yurtdaş M, Durak ZE, Aytaç B, Güneş HN, Çokal BG, Yoldaş TK, Durak I (2016) Oxidative and nitrosative stress in serum of patients with Parkinson’s disease. Neurol Sci 37:1793–1798. https://doi.org/10.1007/s10072-016-2663-1 - DOI - PubMed

Publication types

LinkOut - more resources